Abstract
The actions of released neurotransmitter substances on postsynaptic receptors are generally terminated by the rapid removal of the free transmitter from the synaptic cleft. The classic example of such a mechanism is the metabolic destruction of released acetylcholine by acetylcholinesterase at cholinergic junctions. However, it now seems likely that non-enzymic mechanisms operate at most other chemically transmitting synapses. Such mechanisms involve a physical removal of the released transmitter from its site of action, this removal being catalysed by a variety of different transport systems. The evidence for the existence and function of such uptake systems has been reviewed recently elsewhere (Iversen, 1967, 1971, 1972) and only the salient points will be described here. Most of the transport mechanisms that are associated with neurotransmitter function are located in the membranes of the presynaptic nerve terminals, so that removal of transmitter is equivalent to `recapture’, with the possibility that transmitter molecules may be released, recaptured, and re-used in many cases. There are, however, also examples of transmitter uptake occurring into sites other than the prejunctional terminal, see for example Gillespie, this symposium.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Bennett, J. P. JR., Logan, W.I. & Snyder, S. H. (1972). Science, N. Y., 178, 997.
Blasberg, R. & Lajtha, A. (1965). Archs Biochem. Biophys., 112, 361.
Bogdanski, D. F. & Brodie, B. B. (1969). J. Pharmac. exp. Ther., 165, 181.
Born, G. V. R. & Gillson, R. E. (1959). J. Physiol., Lond., 146, 472.
Brown, G. L. & Gillespie, J. S. (1957). J. Physiol., Lond., 138, 81.
Burgen, A. S. V. & Iversen, L. L. (1965). Br. J. Pharmac. Chem., 25, 34.
Callingham, B. A. (1967). In: Proc. Ist. Int. Symp. Antidepressant Drugs, Milan, 1966.
Coyle, J. T. & Snyder, S. H. (1969). J. Pharmac. exp. Ther., 170, 221.
Curtis, D. R., Duggan, A. W. & Johnston, G. A. R. (1970). Exp. Brain. Res., 10, 447.
Ehinger, B. & Falck, B. (1971). Brain Res., 33, 157.
Elliott, K. A. C. & van Gelder, N. M. (1958). J. Neurochem., 3, 28.
Haeusler, G., Haefely, W. & Hurlimann, A. (1969). N. S. Arch. Pharmac., 265, 260.
Hamberger, B. (1967), Acta physiol. scand. 71, suppl. 295.
Hellman, G., Hertting, G. & Peskar, B. (1971). Br. J. Pharmac., 41, 256.
Hendley, E. D. & Snyder, S. H. (1972). Eur. J. Pharmac., 19, 56.
Hokfelt, T. & Ljungdahl, A. (1970). Brain Res., 22, 391.
Hokfelt, T. & Ljungdahl, A. (1971). Brain Res., 32, 189.
Horn, A. S. (1973). Br. J. Pharmac., 47, 332.
Horn, A. S., Coyle, J. T. & Snyder, S. H. (1971). Mol. Pharmac., 7, 66.
Horn, A. S., Cuello, A. C. & Miller, R. J. (1974). J. Neurochem., 22, 265.
Hughes, J. (1972). Br. J. Pharmac., 44, 472.
Iversen, L. L. (1967). The Uptake and Storage of Noradrenaline in Sympathetic Nerves. London: Cambridge University Press.
Iversen, L. L. (1971). Br. J. Pharmac., 41, 571.
Iversen, L. L. (1972). In: The Role of Biogenic Amines and Physiological Membranes in Modern Drug Therapy, ed. Biel, J. New York: Marcel Dekker.
Iversen, L. L. & Bloom, F. E. (1972). Brain Res., 41, 131.
Iversen, L. L., Jarrott, B. & Simmonds, M. A. (1971). Br. J. Pharmac., 43, 845.
Iversen, L. L. & Johnston, G. A. R. (1971). J. Neurochem., 18, 1939.
Iversen, L. L. & Neal, M. J. (1968). J. Neurochem., 15, 1141.
Jarrott, B. (1970). Br. J. Pharmac., 38, 810.
Johnston, G. A. R. & Iversen, L. L. (1971). J. Neurochem., 18, 1951.
Kopin, I. J. (1968). Ann. Rev. Pharmac., 8, 377.
Kuhar, M. J. & Aghajanian, G. K. (1973). Science, N.Y., 241, 187.
Kuhar, M. J., Roth, R. H. & Aghajanian, G. K. (1972). J. Pharmac. exp. Ther., 181, 36.
Kuhar, M. J., Sethy, V. H., Roth, R. H. & Aghajanian, G. K. (1973). J. Neurochem., 20, 581.
Langer, S. Z. (1970). J. Physiol., Lond., 208, 515.
Levi, G. & Raiteri, M. (1973). Life Sci., 12, 81.
Logan, W. J. & Snyder, S. H. (1972). Brain Res., 42, 413.
Macmillan, W. H. (1959). Br. J. Pharmac., 14, 385.
Malmfors, T. & Thoenen, H. (1971). Eds., 6-Hydroxydopamine and Adrenergic Function. Amsterdam: North Holland.
Matus, A. I. & Dennison, M. E. (1971). Brain Res., 32, 195.
Muscholl, E. (1966). A. Rev. Pharmac., 6, 107.
Neal, M. J. (1971). J. Physiol., Lond., 215, 103.
Neal, M. J. & Pickles, H. (1969). Nature, Lond., 223, 679.
Pletscher, A. (1968). Br. J. Pharmac., 32, 1.
Shaskan, E. A. & Snyder, S. H. (1970). J. Pharmac. exp. Ther., 175, 404.
Sneddon, J. M. (1969). Br. J. Pharmac., 37, 680.
Stacey, R. S. (1961). Br. J. Pharmac., 16, 284.
Strasberg, P. & Elliot, K. A. C. (1967). Can. J. Biochem., 45, 1795.
Theonen, H. (1972). In: Perspectives in Neuropharamacology, ed. Snyder, S. H. New York: Oxford University Press.
Thoenen, H., Hurlimann, A. & Haefely, W. (1964a). J. Pharmac. exp. Ther., 143, 57.
Thoenen, H., Hurlimann, A. & Haefely, W. (1964b). Heiv. Physiol. Pharmac. Acta, 22, 148.
Todrick, A. & Tait, A. C. (1969). J. Pharm. Pharmac., 21, 751.
Weinstein, H., Varon, S., Muhleman, D. R. & Roberts, E. (1965). Biochem. Pharmac., 14, 273.
Whittaker, V. P., Dowdall, M. J. & Boyne, A. F. (1972). Biochem. Soc. Symp., 36, 49.
Whitby, L. G., Axelrod, J. & Weil-Malherbe, H. (1961). J. Pharmac. exp. Ther., 132, 193.
Yamamura, H. I. & Snyder, S. H. (1973). J. Neurochem., 21, 1355.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1973 Institute of Biology Endowment Trust Fund
About this chapter
Cite this chapter
Iversen, L.L. (1973). Neuronal uptake processes for amine and amino acid transmitters. In: Callingham, B.A. (eds) Drugs and Transport Processes. Biological Council. Palgrave, London. https://doi.org/10.1007/978-1-349-02273-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-349-02273-1_16
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-02275-5
Online ISBN: 978-1-349-02273-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)